These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15049605)

  • 41. Compliance with pregnancy prevention plan recommendations in 8672 French women of childbearing potential exposed to acitretin.
    Raguideau F; Mezzarobba M; Zureik M; Weill A; Ricordeau P; Alla F
    Pharmacoepidemiol Drug Saf; 2015 May; 24(5):526-33. PubMed ID: 25753265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acitretin Use in Dermatology.
    Guenther LC; Kunynetz R; Lynde CW; Sibbald RG; Toole J; Vender R; Zip C
    J Cutan Med Surg; 2017; 21(3_suppl):2S-12S. PubMed ID: 28952335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A review of acitretin for the treatment of psoriasis.
    Lee CS; Li K
    Expert Opin Drug Saf; 2009 Nov; 8(6):769-79. PubMed ID: 19998529
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sensorimotor polyneuropathy after a three-month oral acitretin therapy.
    Chroni E; Monastirli A; Pasmatzi E; Sakkis T; Georgiou S; Paschalis C; Tsambaos D
    Clin Neuropharmacol; 2002; 25(6):310-2. PubMed ID: 12469004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acitretin induced bipedal edema.
    Tey HL; Theng TS
    J Dermatol; 2006 May; 33(5):372-4. PubMed ID: 16700673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coexistence of morphea and psoriasis responding to acitretin treatment.
    Bilen N; Apaydin R; Erçin C; Harova G; Başdaş F; Bayramgürler D
    J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):113-7. PubMed ID: 10568490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: a prospective, randomized study.
    Janagond AB; Kanwar AJ; Handa S
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e384-9. PubMed ID: 23066720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature.
    Halverstam CP; Zeichner J; Lebwohl M
    J Cutan Med Surg; 2006; 10(6):291-9. PubMed ID: 17241599
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acitretin: no pregnancy during treatment and, as a precaution, for 3 years after discontinuation.
    Prescrire Int; 2013 Sep; 22(141):213. PubMed ID: 24171216
    [No Abstract]   [Full Text] [Related]  

  • 50. Effectiveness and Safety of Acitretin in Children with Plaque Psoriasis: A Multicenter Retrospective Analysis.
    Di Lernia V; Bonamonte D; Lasagni C; Belloni Fortina A; Cambiaghi S; Corazza M; Di Nuzzo S; Gisondi P; Panzone M; Guarneri C; Neri I
    Pediatr Dermatol; 2016 Sep; 33(5):530-5. PubMed ID: 27443789
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Curcumin nanoparticles potentiate therapeutic effectiveness of acitrein in moderate-to-severe psoriasis patients and control serum cholesterol levels.
    Bilia AR; Bergonzi MC; Isacchi B; Antiga E; Caproni M
    J Pharm Pharmacol; 2018 Jul; 70(7):919-928. PubMed ID: 29600580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases.
    Lam J; Polifka JE; Dohil MA
    J Am Acad Dermatol; 2008 Aug; 59(2):295-315. PubMed ID: 18410980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The acitretin and methotrexate combination therapy for psoriasis vulgaris achieves higher effectiveness and less liver fibrosis.
    An J; Zhang D; Wu J; Li J; Teng X; Gao X; Li R; Wang X; Xia L; Xia Y
    Pharmacol Res; 2017 Jul; 121():158-168. PubMed ID: 28414177
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of total glucosides of paeony combined with acitretin in the treatment of moderate-to-severe plaque psoriasis: a double-blind, randomised, placebo-controlled trial.
    Yu C; Fan X; Li Z; Liu X; Wang G
    Eur J Dermatol; 2017 Apr; 27(2):150-154. PubMed ID: 28400341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current systemic therapies for psoriasis: where are we now?
    Yamauchi PS; Rizk D; Kormeili T; Patnaik R; Lowe NJ
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S66-77. PubMed ID: 12894129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Palmoplantar pustulosis with arthro-osteitis: successful treatment with etanercept and acitretin.
    Antoniou C; Nicolaidou E; Moustou AE; Stratigos A; Katsambas A
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):854-5. PubMed ID: 19646137
    [No Abstract]   [Full Text] [Related]  

  • 57. Punctate palmoplantar keratoderma (Buschke-Fischer-Brauer disease) with psoriasis: a rare association showing excellent response to acitretin.
    Al-Mutairi N; Joshi A; Nour-Eldin O
    J Drugs Dermatol; 2005; 4(5):627-34. PubMed ID: 16167422
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Etretinate may work where acitretin fails.
    Bleiker TO; Bourke JF; Graham-Brown RA; Hutchinson PE
    Br J Dermatol; 1997 Mar; 136(3):368-70. PubMed ID: 9115918
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acitretin-induced transverse leukonychia.
    Zweegers J; Bovenschen HJ
    Int J Dermatol; 2014 Mar; 53(3):e221-2. PubMed ID: 23330614
    [No Abstract]   [Full Text] [Related]  

  • 60. Liraglutide in combination with acitretin for severe recalcitrant psoriasis.
    Reid CT; Tobin AM; Ahern T; O'Shea D; Kirby B
    Br J Dermatol; 2013 Jul; 169(1):230-1. PubMed ID: 23834125
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.